Company Overview
Sales
395
Cr
Growth: -36.4%
Profit after Tax
-417
Cr
Growth:
51.7%
Micro Cap
34.8
Cr
P/S:
0.1x
Industry P/S: 3.1x
Fundamentals
| Sales (Cr) |
₹ 395 |
| Growth |
-36.4% |
| EBITDA |
-32.1% |
| P/S |
0.1x |
| Dividend |
0.0% |
| P/E |
-0.1x |
| Book Value |
₹ -18.5 |
| PEG Ratio |
0.0x |
| ROE |
999.0% |
| P/B |
N/A |
Shareholding Pattern
Institutions
Promoters
Others
Savita Surendra Pai
1.48
%
Virat Kumar Sharma
1.05
%
Increase
Decrease
No change
Sharon Bio-Medicine, established in 1989, is into manufacturing and supply of Active Pharmaceutical Ingredients (APIs). The company has established its name as a reliable supplier of intermediates. In international markets, the company serves Latin America, Middle East, South East Asia and SAARC countries. With the setting up of new facilities Sharon has geared up to enter other markets such as Europe, Japan, Australia and USA in the next two years.
